1. Home
  2. LUMN vs RGEN Comparison

LUMN vs RGEN Comparison

Compare LUMN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumen Technologies Inc.

LUMN

Lumen Technologies Inc.

HOLD

Current Price

$8.07

Market Cap

8.5B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$160.24

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUMN
RGEN
Founded
1968
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.2B
IPO Year
1972
N/A

Fundamental Metrics

Financial Performance
Metric
LUMN
RGEN
Price
$8.07
$160.24
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$5.73
$170.90
AVG Volume (30 Days)
13.7M
724.0K
Earning Date
02-03-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$12,690,000,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
N/A
$12.57
P/E Ratio
N/A
$6,185.26
Revenue Growth
N/A
11.74
52 Week Low
$3.01
$102.97
52 Week High
$11.95
$182.52

Technical Indicators

Market Signals
Indicator
LUMN
RGEN
Relative Strength Index (RSI) 45.06 51.46
Support Level $8.13 $156.31
Resistance Level $8.96 $165.02
Average True Range (ATR) 0.53 4.73
MACD -0.03 -1.26
Stochastic Oscillator 19.80 24.04

Price Performance

Historical Comparison
LUMN
RGEN

About LUMN Lumen Technologies Inc.

Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017 and the 2022 divestiture of much of its local phone business in rural areas and small markets shifted the company's operations away from the legacy consumer business and toward enterprises services, which account for about 75% of revenue. Lumen offers businesses a full suite of communications services, providing colocation and data center services, data transportation, phone service, and internet access. Lumen has announced the sale of its remaining consumer fiber network to AT&T, which will further shift its focus to enterprise customers.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: